Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$113.95 +0.01 (+0.01%)
At close: Nov 10, 2026 · 4:00 PM EST

Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021)

Updated

Rhythm Pharmaceuticals (RYTM) recorded Non-Current Deferred Tax Liability of $7.99 million in Q3 2021, down 53.0% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Rhythm Pharmaceuticals 7.86 Bn 6.48 Bn 79.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 7.99 Mn
Jun 30, 2021 16.98 Mn
Mar 31, 2021 22.01 Mn
API Access

Rhythm Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RYTM&period=max&api_key=YOUR_API_KEY